Serial Number | 88254868 |
Word Mark | MYOVANT SCIENCES |
Filing Date | Wednesday, January 9, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, February 18, 2020 |
Registration Number | 5987696 |
Registration Date | Tuesday, February 18, 2020 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, December 3, 2019 |
Description of Mark | The mark consists a design of three hexagons in a circular formation following by the wording "MYOVANT SCIENCES" in a stylized font. |
Goods and Services | Pharmaceutical preparations for human use for the treatment of prostate cancer, of oncological, endocrinological, and hormonal diseases, disorders and conditions, and of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, and breast diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of prostate cancer, of oncological, endocrinological, and hormonal diseases, disorders and conditions, and of women's health diseases, disorders and conditions in the nature of gynecological, obstetric, and breast diseases, disorders and conditions |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions |
Disclaimer with Predetermined Text | "SCIENCES" |
Goods and Services | Scientific and technological services, namely, medical research, scientific research and analysis, and technological consulting in the fields of pharmaceuticals, biomedicine, clinical trials for others and post-market trials for others; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials for others and post-market trials for others; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 30, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 30, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 30, 2019 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SUMITOMO PHARMA SWITZERLAND GMBH |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 27 - NOT AVAILABLE |
Address | BASEL 4051 CH |
Party Name | Myovant Sciences GmbH |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Basel 4051 CH |
Party Name | Myovant Sciences GmbH |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Basel 4051 CH |
Party Name | Myovant Sciences GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Basel 4051 CH |
Event Date | Event Description |
Wednesday, December 13, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Wednesday, October 26, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, October 26, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, October 26, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, October 26, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, October 26, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, February 18, 2020 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, December 3, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 3, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, November 13, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Saturday, October 26, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, October 26, 2019 | EXAMINER'S AMENDMENT ENTERED |
Saturday, October 26, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Saturday, October 26, 2019 | EXAMINERS AMENDMENT E-MAILED |
Saturday, October 26, 2019 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, October 2, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sunday, September 29, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 29, 2019 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |
Friday, March 29, 2019 | ASSIGNED TO LIE |
Thursday, March 28, 2019 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Thursday, March 28, 2019 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Thursday, March 28, 2019 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Monday, March 25, 2019 | ASSIGNED TO EXAMINER |
Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, January 30, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, January 12, 2019 | NEW APPLICATION ENTERED |